It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Abstract
Objectives
The purpose of this study was to explore the clinical application value of phase angle (PA) of six parts in the nutritional evaluation and construct a prediction model for diagnosing malnutrition of tumor patients.
Methods
A total of 1129 patients with malignant tumors were analyzed retrospectively. The age, sex, tumor location and body mass index (BMI) of the patients were collected, and PA of six parts was measured. The Patient Subjective Global Assessment (PG-SGA) was used to evaluate the nutritional status of each patient.
Results
According to the PG-SGA, 66.5% (n = 750) of the patients were evaluated as malnourished. Patients under the age of 65 had higher PA values. The PA value of men was higher than that of women (except PA-RL). In different disease groups, the PA-RA and PA-TR values were significantly different. In our study, PA value increases with BMI and decreases with PG-SGA (except PG-SGA 0–1 group). Multivariate regression analysis indicates that the age (HR = 1.051, 95% CI 1.037–1.066, P < 0.001), BMI (HR = 0.885, 95% CI 0.849–0.924, P < 0.001), and PA-WB (HR = 0.615, 95% CI 0.546–0.692, P < 0.001) were independent significant predictors associated with malnutrition. The AUC of the prediction model is 0.7631 (p < 0.001), indicating that the model including age, BMI, and PA-WB has certain diagnostic value for the diagnosis of malnutrition.
Conclusion
The PA-WB is an independent prognostic factor of malnutrition. The prediction model constructed by age, BMI, and PA-WB can be used as a useful tool for nutritional evaluation of tumor patients.
Trial registration
Clinical Trial No.: ChiCTR2100047858.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Changzhi People’s Hospital Affiliated to Changzhi Medical College, Department of Oncology, Changzhi, China (GRID:grid.254020.1) (ISNI:0000 0004 1798 4253)
2 Changzhi People’s Hospital Affiliated to Changzhi Medical College, Department of Anesthesiology, Changzhi, China (GRID:grid.254020.1) (ISNI:0000 0004 1798 4253)
3 Changzhi People’s Hospital Affiliated to Changzhi Medical College, Department of Oncology, Changzhi, China (GRID:grid.254020.1) (ISNI:0000 0004 1798 4253); Changzhi Medical College, Department of Respiration, Changzhi, China (GRID:grid.254020.1) (ISNI:0000 0004 1798 4253)
4 Changzhi People’s Hospital Affiliated to Changzhi Medical College, Gastrointestinal Surgery Department, Changzhi, China (GRID:grid.254020.1) (ISNI:0000 0004 1798 4253)